Neurodegeneration in equine grass sickness is not attributable to niacin deficiency by McGorum, B C et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Neurodegeneration in equine grass sickness is not attributable
to niacin deficiency
Citation for published version:
McGorum, BC, Jago, RC, Cillan-Garcia, E, Pirie, RS, Keen, JA, Reardon, RJM, Saffu, PY & Miller, NJ 2017,
'Neurodegeneration in equine grass sickness is not attributable to niacin deficiency' Equine Veterinary
Journal, vol 49, no. 4, pp. 445-447. DOI: 10.1111/evj.12627
Digital Object Identifier (DOI):
10.1111/evj.12627
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Peer reviewed version
Published In:
Equine Veterinary Journal
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 09. May. 2018
A
cc
ep
te
d 
A
rt
ic
le
A
cc
ep
te
d 
A
rt
ic
le
This article has been accepted for publication and undergone full peer review but has not 
been through the copyediting, typesetting, pagination and proofreading process, which may 
lead to differences between this version and the Version of Record. Please cite this article as 
doi: 10.1111/evj.12627 
This article is protected by copyright. All rights reserved. 
Received Date : 11-Mar-2016 
Revised Date   : 06-Jun-2016 
Accepted Date : 11-Aug-2016 
Article type      : General Article 
 
Neurodegeneration in equine grass sickness is not attributable to niacin deficiency 
 
B. C. McGORUM*1, R. C. JAGO1, E. CILLAN-GARCIA1, R. S. PIRIE1, J. A. KEEN1, R. J. 
M. REARDON1, P. Y. SAFFU2 and N. J. MILLER2 
1The Royal (Dick) School of Veterinary Studies and Roslin Institute, The University of 
Edinburgh, Easter Bush Campus, Edinburgh, Midlothian, EH25 9RG, UK. 
2Biolab Medical Unit, 9 Weymouth Street, London, W1W 6DB, UK. 
 
*Corresponding author email:  bruce.mcgorum@ed.ac.uk 
    
Keywords: horse; grass sickness; dysautonomia; B vitamins; niacin; nicotinic acid 
 
Summary 
Background: The aetiology of equine grass sickness (EGS) is currently unknown. We 
hypothesised that acute deficiency of niacin (vitamin B3), which has a key role in neural 
homeostasis, may contribute to neurodegeneration in EGS. Niacin deficiency could 
potentially result from ingestion of niacin antagonists produced by pasture mycotoxigenic 
fungi.  
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Objectives: To compare the niacin status of EGS and control grazing horses. A secondary 
objective was to compare blood concentrations of vitamins B1, B2 and B6 in EGS and 
control grazing horses to determine if the status of these vitamins was altered in EGS. 
Study design: Case-control study.  
Methods: Indices of niacin status, namely the erythrocyte nicotinamide adenine 
dinucleotide:nicotinamide adenine dinucleotide phosphate ratio (NAD:NADP ratio) and 
erythrocyte concentrations of NAD and NADP, were compared in blood collected from EGS 
and healthy control grazing horses. Blood concentrations of vitamins B1, B2 and B6 were 
also compared. 
Results: There was no significant inter-group difference in the NAD:NADP ratio, the main 
index of functional niacin status (control median 2.1, interquartile range 1.8-2.6; EGS 2.1, 
1.9-2.6). EGS horses had significantly higher (median value increased by 25%) 
concentrations of NADP. There were no inter-group differences in blood concentrations of 
vitamins B1, B2 and B6.  
Main limitations: Interpretation of data was limited by lack of previously defined equine 
reference ranges for many of the analytes. Sample size was low.  
Conclusions: Niacin deficiency does not contribute to EGS neurodegeneration.  
 
Introduction 
The aetiology of equine grass sickness (EGS), a multi-system neuropathy typically affecting 
grazing horses [1], is unknown. We hypothesised that EGS represents an acute deficiency of 
niacin (also termed vitamin B3 and nicotinic acid) and its derivatives, the coenzymes NAD 
and NADP. Niacin deficiency, termed pellagra, causes neurodegeneration because NAD and 
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NADP have essential roles in redox reactions and as cofactors for many enzymes key to 
neural homeostasis [2,3]. Consequently, niacin and its cofactors have important roles in 
treating neurodegeneration [4,5] and could be of potential use for treatment of EGS. 
We hypothesised that acute niacin deficiency could be induced by ingestion of niacin 
antagonists such as 6-aminonicotinamide, 3-acetylpyridine, 3-aminopyridine, indole, 
quinolines and picolinic acid. Some of these antagonists are produced by Fusarium spp. [6] 
which are present in increased numbers on grasses in EGS fields [7] and which are currently 
being investigated as a potential cause of EGS (R.S. Pirie, personal communication). 
Consistent with this hypothesis, human acute neurologic pellagra may be caused by ingestion 
of mycotoxin contaminated maize [8], and administration of niacin antagonists produces 
acute neurologic disease in experimental animals [9-11]. Establishing a definitive causal link 
between mycotoxin ingestion and disease can be difficult; consequently, the identification of 
specific biomarkers of mycotoxin activity was considered a potential indirect means of 
supporting such a link. 
EGS, human acute neurologic pellagra and experimental neurologic pellagra share many 
similarities, including some common neuro-anatomic targets (including enteric neurons, 
dorsal root ganglia, brainstem nuclei), nature of neurodegeneration (central chromatolysis), 
and some key clinical signs (weight loss, anorexia, muscle weakness, ptosis, abdominal 
discomfort, abdominal distension, constipation, tremors, dysphagia and hypotension) [12-18]. 
Human pellagra also induces alterations in the serum amino acid profile [19,20] resembling 
those reported for EGS [21]. It should be noted that this acute niacin deficiency hypothesis 
contrasts with chronic niacin deficiency which results from longer term dietary inadequacy 
and which causes a different range of symptoms. 
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In this study, indices of niacin status including erythrocyte NAD:NADP ratio and 
concentrations of NAD and NADP were compared in blood collected from EGS horses and 
healthy control horses which were grazing fields where EGS had not occurred. In niacin 
deficiency levels of the niacin coenzymes NAD and NADP are disproportionately 
maintained, with NAD levels falling while NADP is maintained at a stable level [3]. 
Consequently a reduced ratio of erythrocyte NAD to NADP suggests niacin deficiency. 
Blood concentrations of vitamins B1, B2 and B6 were also compared to determine if the 
status of these vitamins was altered in EGS. 
 
Materials and Methods 
Collection of blood 
Heparinised venous blood samples were collected from 10 mixed-breed horses with EGS (8 
acute and 2 sub-acute cases; median age 7 years, IQR 5-8.3; 4 geldings, 6 females). EGS was 
categorised as previously described [21] and confirmed by post mortem examination 
including histopathological examination of autonomic ganglia [22]. Blood samples were also 
obtained from 12 control mixed-breed clinically healthy horses (median age 12 years, IQR 9-
20; 8 geldings, 4 females) from 3 premises (with 8, 3 and one horse on each premise) that 
were grazing fields where EGS had not occurred. Heparinised whole blood was posted to 
arrive at the laboratory within 24 h of collection.  
Vitamin assays  
A method for measuring erythrocyte NAD and NADP levels, based on the enzymatic cycling 
method of Nisselbaum and Green (1969) [23] was used to assess vitamin B3 status in blood 
samples. Vitamin B1 (thiamine), vitamin B2 (riboflavin) and vitamin B6 (pyridoxine) were 
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measured using coenzyme stimulation assays [24]. Results were expressed as the ratio of 
activated to basal enzyme activity corrected for haemoglobin concentration. 
 
Data analysis 
The Mann-Whitney U test was used to compare age and concentrations of analytes in EGS 
and control groups, assuming significance at P<0.05. Sample size estimates with 80% power 
and 95% confidence were conducted using effect sizes and pooled standard deviations 
estimated from the data. All statistical analyses were performed using Minitab®a. 
 
Results 
There was no statistically significant inter-group age difference. There was no significant 
inter-group difference in the NAD:NADP ratio, the main index of niacin status (Table 1). A 
sample size estimate indicated that 68,496 horses would be required in each group to identify 
significant inter-group differences in this index. EGS horses had significantly (P = 0.02) 
higher concentrations of NADP. There was no significant inter-group difference in NAD 
concentration and in the sum of NAD and NADP concentrations. There were no significant 
inter-group differences in the blood concentrations of vitamins B1, B2 and B6 (Table 1). 
Sample size estimates indicated that 35, 81 and 36 horses would be required in each group to 
identify significant inter-group differences in vitamin B1, B2 and B6 concentrations, 
respectively. 
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Discussion 
In this study, the main index of functional niacin status, the NAD:NADP ratio, was almost 
identical in EGS and control horses, indicating that neurodegeneration in EGS is not a 
consequence of deficiency of niacin and its derivatives NAD and NADP.  
 
There are few published data regarding niacin biology in the horse. Niacin is synthesised in 
the liver from tryptophan [25] and by intestinal microbes [26,27]. Niacin deficiency has not 
been reported in the horse, there are no National Research Council recommendations for 
dietary requirements of niacin in horses [28] and there are no published reference ranges for 
indices of niacin status in the horse. While Parker et al. (1997) [29] reported that horses 
would be considered niacin deficient based on human reference ranges for NADP:NADP 
ratio, actual data were not presented. In the current study, the NAD:NADP ratio of control 
grazing horses (median 2.1, IQR 1.8-2.6) was considerably lower than the mean ratio for 
humans (3.3) [3,30]. Applying criteria used to interpret human NAD:NADP ratios, many 
horses in the current study would be considered to have mild (ratio of 2.1–2.5; 3 EGS and 4 
control horses) or marked (ratio <2.1; 5 EGS and 4 control horses) niacin deficiency. 
Similarly, applying criteria used to interpret human blood NAD (reference range 200-300 
nmol/mL RBC) and NADP (reference range 60-100 µmol/L RBC) concentrations, all horses 
except one EGS horse would be considered to have low concentrations of NAD, and all 
horses except 5 EGS horses would be considered to have low concentrations of NADP. 
However, rather than indicating that healthy horses are niacin deficient, it is more likely that 
these data and those of Parker et al. (1997) [29] indicate that the reference ranges for 
NAD:NADP ratios and for blood concentrations of NAD and NADP for healthy horses are 
lower than those for humans.  
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Despite EGS and control horses having almost identical NAD:NADP ratios, EGS horses had 
significantly higher (median value increased by 25%) concentrations of NADP. This may 
reflect upregulation of NAD synthetic pathways in EGS in an attempt to promote vital and/or 
regulatory functions [2,4]. 
 
EGS was not associated with significant alterations in blood concentrations of vitamins B1, 
B2 and B6. Comparison of data for these vitamins with published data is not possible because 
of absence of published reference ranges for some analytes and differences in the units in 
which some analytes are expressed (IU/gHb in the present study). The current data, in 
combination with those derived from a previous study demonstrating adequate vitamin B12 
status in EGS [31], indicate that the overall vitamin B status is maintained, at least in the 
early stages of EGS, despite the intestinal dysbiosis which occurs in EGS [32,33] potentially 
reducing the synthesis of B vitamins by intestinal microbes.  
 
While sample sizes were low, a significant inter-group difference was observed in NADP 
concentrations. Sample size estimates indicated that lack of significant inter-group 
differences in concentrations of NAD and vitamins B1, B2 and B3 may have been the result 
of low sample size. However a very large sample size (68,496 horses per group) would have 
been required to identify a significant inter-group difference in NAD:NADP ratio, suggesting 
that there is unlikely to be an association between EGS and a low index of functional niacin 
status. However because of lack of reference range data for the analytes, sample size 
estimations were calculated using the study data rather than using clinically relevant effect 
sizes. 
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Table 1: Indices of niacin status, including erythrocyte NAD:NADP ratio, erythrocyte concentrations of NAD and NADP and sum of 
erythrocyte concentrations of NAD and NADP (µmol/L RBC), and concentrations of vitamins B1, B2 and B6 (IU/gHb) in blood from control (n 
= 12) and EGS (n = 10) horses. Median and Q1-Q3.  
 
Group NAD: NADP 
Ratio 
NAD NADP NAD+NADP Vitamin B1 Vitamin B2 Vitamin B6 
Control 2.1 
1.8-2.6 
96.5 
87.5-131.0 
48.0* 
42.3-52.3 
144 
133-178 
1.17 
1.01-1.30 
1.85 
1.33-1.98 
1.19 
1.08-1.43 
EGS 2.1 
1.9-2.6 
122.5 
101.7-143.3 
60.0* 
49.4-62.3 
180 
148-200 
1.07 
1.00-1.18 
1.44 
1.17-1.99 
1.46 
1.20-1.69 
 
*Significant inter-group difference P = 0.02 
